Update on skin repigmentation therapies in vitiligo

Pigment Cell and Melanoma Research

Volumn 22, Issue 1, 2009, Pages 42-65

  Falabella, Rafael ^a   Barona, Maria I ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Depigmentation; Medical; Repigmentation; Surgical; Therapy; Vitiligo

Indexed keywords

BETAMETHASONE; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CATALASE; CLOBETASOL; CORTICOSTEROID; DEXAMETHASONE; FLUOROURACIL; HYDROCORTISONE; KHELLIN; MELAGENINA; METHOXSALEN; PHENYLALANINE; PIMECROLIMUS; PLACENTA EXTRACT; POLYPODIUM LEUCOTOMOS EXTRACT; PREDNISOLONE; PSORALEN DERIVATIVE; SUPEROXIDE DISMUTASE; TACALCITOL; TACROLIMUS; TRIMETHYLPSORALEN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CELL CYCLE ARREST; DEPIGMENTATION; EXCIMER LASER; GASTROINTESTINAL SYMPTOM; HELIUM NEON LASER; HUMAN; MELANOGENESIS; MENTAL STRESS; PATIENT ASSESSMENT; PATIENT SELECTION; PHOTOTHERAPY; PHYTOTHERAPY; POSTOPERATIVE COMPLICATION; PSYCHOTHERAPY; PUVA; REVIEW; SCAR FORMATION; SKIN GRAFT; SKIN PIGMENTATION; SURGICAL APPROACH; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

DERMATOLOGIC AGENTS; HUMANS; PUVA THERAPY; SKIN PIGMENTATION; SKIN TRANSPLANTATION; VITILIGO;

EID: 58649084131     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00528.x     Document Type: Review

References (250)

1. Abdallah, M., Abdel-Naser, M.B., Moussa, M.H., Assaf, C. Orfanos, C.E. (2003). Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. Eur. J. Dermatol. 13, 548 552.
2. Abdel-Fattah, A., Aboul-Enein, M.N., Wassel, G.M. El-Menshawi, B.S. (1982). An approach to the treatment of vitiligo by khellin. Dermatologica 165, 136 140.
3. Abdel-Naser, M.B., El-Khateeb, E.A., Sallam, T.H. Habib, M.A. (2006). Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A. Clin. Exp. Dermatol. 31, 571 575.
4. Acikel, C., Ulkur, E. Celikoz, B. (2003). Carbon dioxide laser resurfacing and thin skin grafting in the treatment of "stable and recalcitrant" vitiligo. Plast. Reconstr. Surg. 111, 1291 1298.
5. Acikel, C., Ulkur, E. Celikoz, B. (2007). Application of lasers in transplantation procedures for vitiligo. In Surgical Management of Vitiligo, S. Gupta, M.J. Olsson, A.J. Kanwar J.P. Ortonne, eds (Singapore : Blackwell Publishing pp. 259 266.
6. Agarwal, U.S., Gulati, R., Shukla, S.R. Mathur, N. (2004). Satellite repigmentation after punch grafting. Int. J. Dermatol. 43, 273 274.
7. Agrawal, K. Agrawal, A. (1995). Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft. Dermatol. Surg. 21, 295 300.
8. Albert, S. Shenoi, S.D. (2001). Acetate sheets in the transfer of epidermal grafts in vitiligo. J. Am. Acad. Dermatol. 44, 719 720.
9. Ameen, M., Exarchou, V. Chu, A.C. (2001). Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br. J. Dermatol. 145, 476 479.
10. Anbar, T., Westerhof, W., Abdel-Rahman, A., El-Khayyat, M. El-Metwally, Y. (2006a). Treatment of periungual vitiligo with erbium-YAG-laser plus 5-flurouracil: a left to right comparative study. J. Cosmet. Dermatol. 5, 135 139.
11. Anbar, T.S., Westerhof, W., Abdel-Rahman, A.T. El-Khayyat, M.A. (2006b). Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol. Photoimmunol. Photomed. 22, 157 163.
12. Andreassi, L., Pianigiani, E., Andreassi, A., Taddeucci, P. Biagioli, M. (1998). A new model of epidermal culture for the surgical treatment of vitiligo. Int. J. Dermatol. 37, 595 598.
13. Arca, E., Tastan, H.B., Erbil, A.H., Sezer, E., Koc, E. Kurumlu, Z. (2006). Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J. Dermatol. 33, 338 343.
14. Babu, A., Thappa, D.M. Jaisankar, T.J. (2008). Punch grafting versus suction blister epidermal grafting in the treatment of stable lip vitiligo. Dermatol. Surg. 34, 166 178.
15. Bakos, L. Bakos, R.M. (2007). Focal acne during topical tacrolimus therapy for vitiligo. Arch. Dermatol. 143, 1223 1224.
16. Beck, A.J., Phillips, J., Smith-Thomas, L., Short, R.D. MacNeil, S. (2003). Development of a plasma polymerized surface suitable for the transplantation of keratinocyte-melanocyte cocultures for patients with vitiligo. Tissue Eng. 9, 1123 1131.
17. Behl, P.N. Bhatia, R.K. (1973). Treatment of vitiligo with autologous thin Thiersch's grafts. Int. J. Dermatol. 12, 329 331.
18. Bhatnagar, A., Kanwar, A.J., Parsad, D. De, D. (2007a). Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J. Eur. Acad. Dermatol. Venereol. 21, 1381 1385.
19. Bhatnagar, A., Kanwar, A.J., Parsad, D., Narang, T. De, D. (2007b). Confetti-like hypopigmentation: a rare complication of common phototherapeutic modality. J. Eur. Acad. Dermatol. Venereol. 21, 1276 1277.
20. Birlea, S.A., Costin, G.E. Norris, D.A. (2008). Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr. Drug Targets 9, 345 359.
21. Boersma, B.R., Westerhof, W. Bos, J.D. (1995). Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J. Am. Acad. Dermatol. 33, 990 995.
22. Boissy, R.E., Liu, Y.Y., Medrano, E.E. Nordlund, J.J. (1991). Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J. Invest. Dermatol. 97, 395 404.
23. Boone, B., Ongenae, K., Van Geel, N., Vernijns, S., De Keyser, S. Naeyaert, J.M. (2007). Topical pimecrolimus in the treatment of vitiligo. Eur. J. Dermatol. 17, 55 61.
24. Brazzelli, V., Prestinari, F., Castello, M., Bellani, E., Roveda, E., Barbagallo, T. Borroni, G. (2005). Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatr. Dermatol. 22, 257 261.
25. Brazzelli, V., Barbagallo, T., Prestinari, F., Vassallo, C., Agozzino, M., Vailati, F., Cespa, M. Borroni, G. (2006). Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy. Photodermatol. Photoimmunol. Photomed. 22, 211 213.
26. Brazzelli, V., Antoninetti, M., Palazzini, S., Barbagallo, T., De Silvestri, A. Borroni, G. (2007). Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J. Eur. Acad. Dermatol. Venereol. 21, 1369 1374.
27. Brysk, M.M., Newton, R.C., Rajaraman, S., Plott, T., Barlow, E., Bell, T., Penn, P. Smith, E.B. (1989). Repigmentation of vitiliginous skin by cultured cells. Pigment Cell Res. 2, 202 207.
28. Camacho, F. Mazuecos, J. (1999). Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. Arch. Dermatol. 135, 216 217.
29. Camacho, F. Mazuecos, J. (2002). Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight - a new study for the treatment of vitiligo. J. Drugs Dermatol. 1, 127 131.
30. Cario-Andre, M., Pain, C., Gauthier, Y., Casoli, V. Taieb, A. (2006). In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res. 19, 434 442.
31. Cario-Andre, M., Pain, C., Gauthier, Y. Taieb, A. (2007). The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res. 20, 385 393.
32. Carlie, G., Ntusi, N.B., Hulley, P.A. Kidson, S.H. (2003). KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. Br. J. Dermatol. 149, 707 717.
33. Casacci, M., Thomas, P., Pacifico, A., Bonnevalle, A., Paro Vidolin, A. Leone, G. (2007). Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo-a multicentre controlled study. J. Eur. Acad. Dermatol. Venereol. 21, 956 963.
34. Chen, Y.F., Yang, P.Y., Hu, D.N., Kuo, F.S., Hung, C.S. Hung, C.M. (2004). Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J. Am. Acad. Dermatol. 51, 68 74.
35. Chen, G.Y., Hsu, M.M., Tai, H.K., Chou, T.C., Tseng, C.L., Chang, H.Y., Lan, C.C. Sheu, H.M. (2005). Narrow-band UVB treatment of vitiligo in Chinese. J. Dermatol. 32, 793 800.
36. Cockayne, S.E., Messenger, A.G. Gawkrodger, D.J. (2002). Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well. J. Am. Acad. Dermatol. 46, 964 965.
37. Cormane, R.H., Siddiqui, A.H., Westerhof, W. Schutgens, R.B. (1985). Phenylalanine and UVA light for the treatment of vitiligo. Arch. Dermatol. Res. 277, 126 130.
38. Cormane, R.H., Siddiqui, A.H., Westerhof, W., Schutgens, R.B.H., Hu, R. Mohan, V.I. (1986). Proceedings of the 236th Meeting of the Netherlands Society for Dermatology and Venereology, Amsterdam, 1 February 1986. Br. J. Dermatol. 115, 583 594.
39. Coskun, B., Saral, Y. Turgut, D. (2005). Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. Eur. J. Dermatol. 15, 88 91.
40. Cui, J., Shen, L.Y. Wang, G.C. (1991). Role of hair follicles in the repigmentation of vitiligo. J. Invest. Dermatol. 97, 410 416.
41. Dawid, M., Veensalu, M., Grassberger, M. Wolff, K. (2006). Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study. J. Dtsch. Dermatol. Ges. 4, 942 946.
42. Day, I. Lin, A.N. (2008). Use of pimecrolimus cream in disorders other than atopic dermatitis. J. Cutan. Med. Surg. 12, 17 26.
43. De, D. Kanwar, A.J. (2008). Tacrolimus-induced hyperpigmentation in a patch of vitiligo. Skinmed 7, 93 94.
44. Dell'anna, M.L. Picardo, M. (2006). A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 19, 406 411.
45. Dell'Anna, M.L., Mastrofrancesco, A., Sala, R., Venturini, M., Ottaviani, M., Vidolin, A.P., Leone, G., Calzavara, P.G., Westerhof, W. Picardo, M. (2007). Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin. Exp. Dermatol. 32, 631 636.
46. Drake, L.A., Dinehart, S.M., Farmer, E.R. et al. (1996a). Guidelines of care for vitiligo. American Academy of Dermatology. J. Am. Acad. Dermatol. 35, 620 626.
47. Drake, L.A., Dinehart, S.M., Farmer, E.R. et al. (1996b). Guidelines of care for photoaging/photodamage. American Academy of Dermatology. J. Am. Acad. Dermatol. 35, 462 464.
48. El-Ghorr, A.A. Norval, M. (1997). Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J. Photochem. Photobiol. 38, 99 106.
49. El-Mofty, M., Mostafa, W., Youssef, R., El-Fangary, M., Elramly, A.Z., Mahgoub, D. Fawzy, M. (2006). Ultraviolet A in vitiligo. Photodermatol. Photoimmunol. Photomed. 22, 214 216.
50. Eves, P.C., Bullett, N.A., Haddow, D., Beck, A.J., Layton, C., Way, L., Shard, A.G., Gawkrodger, D.J. Mac Neil, S. (2008). Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J. Invest. Dermatol. 128, 1554 1564.
51. Fai, D., Cassano, N. Vena, G.A. (2007). Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J. Eur. Acad. Dermatol. Venereol. 21, 916 920.
52. Falabella, R. (1971). Epidermal grafting. An original technique and its application in achromic and granulating areas. Arch. Dermatol. 104, 592 600.
53. Falabella, R. (1983). Repigmentation of segmental vitiligo by autologous minigrafting. J. Am. Acad. Dermatol. 9, 514 521.
54. Falabella, R. (1984). Repigmentation of leukoderma by autologous epidermal grafting. J. Dermatol. Surg. Oncol. 10, 136 144.
55. Falabella, R. (1996). Surgical techniques for repigmentation. In Atlas of Cutaneous Surgery, S.K. Robinson, K.A. Arndt, P.E. LeBoit B.U. Wintroub, eds (Philadelphia : W.B. Saunders Co pp. 175 184.
56. Falabella, R. (2000). Surgical therapies for vitiligo. In Vitiligo, S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science Ltd pp. 193 200.
57. Falabella, R. (2004). The minigrafting test for vitiligo: validation of a predicting tool. J. Am. Acad. Dermatol. 51, 672 673.
58. Falabella, R. (2005). Surgical approaches for stable vitiligo. Dermatol. Surg. 31, 1277 1284.
59. Falabella, R., Escobar, C. Borrero, I. (1989). Transplantation of in vitro cultured epidermis bearing melanocytes for repigmenting vitiligo. J. Am. Acad. Dermatol. 21, 257 264.
60. Falabella, R., Escobar, C. Borrero, I. (1992). Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J. Am. Acad. Dermatol. 26, 230 236.
61. Falabella, R., Arrunategui, A., Barona, M.I. Alzate, A. (1995a). The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J. Am. Acad. Dermatol. 32, 228 232.
62. Falabella, R., Barona, M., Escobar, C., Borrero, I. Arrunategui, A. (1995b). Surgical combination therapy for vitiligo and piebaldism. Dermatol. Surg. 21, 852 857.
63. Forschner, T., Buchholtz, S. Stockfleth, E. (2007). Current state of vitiligo therapy-evidence-based analysis of the literature. J. Dtsch. Dermatol. Ges. 5, 467 475.
64. Gauthier, Y. (1995). Techniques of melanocyte graft. Ann. Dermatol. Venereol. 122, 627 631.
65. Gauthier, Y. Surleve-Bazeille, J.E. (1992). Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J. Am. Acad. Dermatol. 26, 191 194.
66. van Geel, N., Ongenae, K., De Mil, M. Naeyaert, J.M. (2001). Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol. Surg. 27, 873 876.
67. van Geel, N., Ongenae, K., De Mil, M., Haeghen, Y.V., Vervaet, C. Naeyaert, J.M. (2004). Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch. Dermatol. 140, 1203 1208.
68. van Geel, N., Ongenae, K., Vander Haeghen, Y., Vervaet, C. Naeyaert, J.M. (2006). Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo. Dermatology 213, 23 29.
69. Ghorpade, A. (2004). Use of tissue glue for punch grafting in vitiligo-a preliminary report. Indian J. Dermatol. Venereol. Leprol. 70, 159 161.
70. Ghosh, D., Shenoy, S. Kuchroo, P. (2008). Cultured melanocytes: from skin biopsy to transplantation. Cell Transplant. 17, 351 360.
71. Goktas, E.O., Aydin, F., Senturk, N., Canturk, M.T. Turanli, A.Y. (2006). Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 553 557.
72. Graham-Brown, R. (1992). Toxicity of Chinese herbal remedies (letter). Lancet 340, 673.
73. Greiner, D., Ochsendorf, F.R. Milbradt, R. (1994). Vitiligo therapy with phenylalanine/UV A. Catamnestic studies after five years. Hautarzt 45, 460 463.
74. Greve, B., Raulin, C. Fischer, E. (2006). Excimer laser treatment of vitiligo - critical retrospective assessment of own results and literature overview. J. Dtsch. Dermatol. Ges. 4, 32 40.
75. Grichnik, J.M., Ali, W.N., Burch, J.A., Byers, J.D., Garcia, C.A., Clark, R.E. Shea, C.R. (1996). KIT expression reveals a population of precursor melanocytes in human skin. J. Invest. Dermatol. 106, 967 971.
76. Grimes, P.E. (2004). White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J. Am. Acad. Dermatol. 51, S5 S7.
77. Grimes, P.E. Billips, M. (2000). Childhood vitiligo: clinical spectrum and therapeutic approaches. In Vitiligo, S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science, Inc pp. 61 69.
78. Grimes, P.E., Minus, H.R., Chakrabarti, S.G., Enterline, J., Halder, R., Gough, J.E. Kenney Jr., J.A. (1982). Determination of optimal topical photochemotherapy for vitiligo. J. Am. Acad. Dermatol. 7, 771 778.
79. Grimes, P.E., Soriano, T. Dytoc, M.T. (2002). Topical tacrolimus for repigmentation of vitiligo. J. Am. Acad. Dermatol. 47, 789 791.
80. Guerra, L., Capurro, S., Melchi, F., Primavera, G., Bondanza, S., Cancedda, R., Luci, A., De Luca, M. Pellegrini, G. (2000). Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. Arch. Dermatol. 136, 1380 1389.
81. Guerra, L., Primavera, G., Raskovic, D. et al. (2003). Erbium: YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch. Dermatol. 139, 1303 1310.
82. Gupta, S. Kumar, B. (2003). Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J. Am. Acad. Dermatol. 49, 99 104.
83. Gupta, S., Shroff, S. Gupta, S. (1999). Modified technique of suction blistering for epidermal grafting in vitiligo. Int. J. Dermatol. 38, 306 309.
84. Gupta, S., Sandhu, K., Kanwar, A. Kumar, B. (2004). Melanocyte transfer via epidermal grafts for vitiligo of labial mucosa. Dermatol. Surg. 30, 45 48.
85. Gupta, S., Goel, A., Kanwar, A.J. Kumar, B. (2006). Autologous melanocyte transfer via epidermal grafts for lip vitiligo. Int. J. Dermatol. 45, 747 750.
86. Gupta, S., Goel, A. Kanwar, A.J. (2007). Surgical management of lip vitiligo. In Surgical Management of Vitiligo. B.S. Gupta, M.J. Olsson, A.J. Kanwar J.P. Ortonne, eds (Singapore : Blackwell Publishing pp. 211 219.
87. Hadi, S., Tinio, P., Al-Ghaithi, K., Al-Qari, H., Al-Helalat, M., Lebwohl, M. Spencer, J. (2006). Treatment of vitiligo using the 308-nm excimer laser. Photomed. Laser Surg. 24, 354 357.
88. Hamzavi, I., Jain, H., McLean, D., Shapiro, J., Zeng, H. Lui, H. (2004). Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch. Dermatol. 140, 677 683.
89. Handa, S., Pandhi, R. Kaur, I. (2001). Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients. J. Dermatol. 28, 461 466.
90. Hann, S.K. Nordlund, J.J. (2000). Definition of vitligo. In Vitiligo. S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science, Inc pp. 3 6.
91. Hann, S.K., Cho, M.Y., Im, S. Park, Y.K. (1991). Treatment of vitiligo with oral 5-methoxypsoralen. J. Dermatol. 18, 324 329.
92. Hann, S.K., Im, S., Park, Y.K. Hur, W. (1992). Repigmentation of leukotrichia by epidermal grafting and systemic psoralen plus UV-A. Arch. Dermatol. 128, 998 999.
93. Hann, S.K., Im, S., Bong, H.W. Park, Y.K. (1995). Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J. Am. Acad. Dermatol. 32, 943 948.
94. Hartmann, A., Lurz, C., Hamm, H., Brocker, E.B. Hofmann, U.B. (2005). Narrow-band UVB 311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int. J. Dermatol. 44, 736 742.
95. Hartmann, A., Brocker, E.B. Hamm, H. (2008). Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion. J. Dtsch. Dermatol. Ges. 6, 383 385.
96. Hasegawa, T., Suga, Y., Ikejima, A., Muramatsu, S., Mizuno, Y., Tsuchihashi, H., Haruna, K., Ogawa, H. Ikeda, S. (2007). Suction blister grafting with CO(2) laser resurfacing of the graft recipient site for vitiligo. J. Dermatol. 34, 490 492.
97. Hassab-El-Naby, H.M., Al-Ajmi, H.S., Al-Sabah, H.Y. Kajeji, M.M. (2006). PUVA keratosis in vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 1013 1014.
98. Hatchome, N., Kato, T. Tagami, H. (1990). Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon. J. Am. Acad. Dermatol. 22, 87 91.
99. Herr, H., Cho, H.J. Yu, S. (2007). Burns caused by accidental overdose of photochemotherapy (PUVA). Burns 33, 372 375.
100. Hirobe, T. (2005). Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 18, 2 12.
101. Hofer, A., Kerl, H. Wolf, P. (2001). Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur. J. Dermatol. 11, 225 229.
102. Hofer, A., Hassan, A.S., Legat, F.J., Kerl, H. Wolf, P. (2005). Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br. J. Dermatol. 152, 981 985.
103. Hofer, A., Hassan, A.S., Legat, F.J., Kerl, H. Wolf, P. (2006). The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J. Eur. Acad. Dermatol. Venereol. 20, 558 564.
104. Horikawa, T., Norris, D.A., Yohn, J.J., Zekman, T., Travers, J.B. Morelli, J.G. (1995). Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J. Invest. Dermatol. 104, 256 259.
105. Horikawa, T., Mishima, Y., Nishino, K. Ichihashi, M. (1999). Horizontal and vertical pigment spread into surrounding piebald epidermis and hair follicles after suction blister epidermal grafting. Pigment Cell Res. 12, 175 180.
106. Imokawa, G., Kobayashi, T., Miyagishi, M., Higashi, K. Yada, Y. (1997). The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res. 10, 218 228.
107. Jin, Y., Mailloux, C.M., Gowan, K., Riccardi, S.L., LaBerge, G., Bennett, D.C., Fain, P.R. Spritz, R.A. (2007). NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216 1225.
108. Juhlin, L. Olsson, M.J. (1997). Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm. Venereol. 77, 460 462.
109. Kahn, A.M. Cohen, M.J. (1995). Vitiligo: treatment by dermabrasion and epithelial sheet grafting. J. Am. Acad. Dermatol. 33, 646 648.
110. Kahn, A.M. Cohen, M.J. (1998). Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts. Dermatol. Surg. 24, 365 367.
111. Kahn, A.M., Cohen, M.J., Kaplan, L. Highton, A. (1993). Vitiligo: treatment by dermabrasion and epithelial sheet grafting-a preliminary report. J. Am. Acad. Dermatol. 28, 773 774.
112. Kang, H.Y. Choi, Y.M. (2006). FK506 increases pigmentation and migration of human melanocytes. Br. J. Dermatol. 155, 1037 1040.
113. Kanwar, A.J. Dogra, S. (2005). Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol. 30, 332 336.
114. Kaufmann, R., Greiner, D., Kippenberger, S. Bernd, A. (1998). Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm. Venereol. 78, 136 138.
115. Kemp, E.H., Waterman, E.A. Weetman, A.P. (2001). Autoimmune aspects of vitiligo. Autoimmunity 34, 65 77.
116. Kent, G. al-Abadie, M. (1996). Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin. Exp. Dermatol. 21, 330 333.
117. Kim, H.U. Yun, S.K. (2000). Suction device for epidermal grafting in vitiligo: employing a syringe and a manometer to provide an adequate negative pressure. Dermatol. Surg. 26, 702 704.
118. Kim, S.M., Lee, H.S. Hann, S.K. (1999). The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int. J. Dermatol. 38, 546 550.
119. Kim, C.Y., Yoon, T.J. Kim, T.H. (2001a). Epidermal grafting after chemical epilation in the treatment of vitiligo. Dermatol. Surg. 27, 855 856.
120. Kim, Y.J., Chung, B.S. Choi, K.C. (2001b). Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatol. Surg. 27, 969 970.
121. Koga, M. (1988). Epidermal grafting using the tops of suction blisters in the treatment of vitiligo. Arch. Dermatol. 124, 1656 1658.
122. Kuiters, G.R., Hup, J.M., Siddiqui, A.H. Cormane, R.H. (1986). Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J. Trop. Med. Hyg. 89, 149 155.
123. Kumari, J. (1984). Vitiligo treated with topical clobetasol propionate. Arch. Dermatol. 120, 631 635.
124. Kwinter, J., Pelletier, J., Khambalia, A. Pope, E. (2007). High-potency steroid use in children with vitiligo: a retrospective study. J. Am. Acad. Dermatol. 56, 236 241.
125. Kwok, Y.K., Anstey, A.V. Hawk, J.L. (2002). Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study. Clin. Exp. Dermatol. 27, 104 110.
126. Lahiri, K., Malakar, S., Sarma, N. Banerjee, U. (2006). Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)-a prospective study. Int. J. Dermatol. 45, 649 655.
127. Lan, C.C., Chen, G.S., Chiou, M.H., Wu, C.S., Chang, C.H. Yu, H.S. (2005). FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br. J. Dermatol. 153, 498 505.
128. Lan, C.C., Wu, C.S., Chiou, M.H., Hsieh, P.C. Yu, H.S. (2006). Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro. J. Invest. Dermatol. 126, 2119 2126.
129. Lawrence, I.D. (1998). Tacrolimus (FK 506): experience in dermatology. Dermatol. Ther. 5, 74 84.
130. Laxmisha, C. Thappa, D.M. (2005a). Reliable site for suction blister induction and harvesting. Indian J. Dermatol. Venereol. Leprol. 71, 321 324.
131. Laxmisha, C. Thappa, D.M. (2005b). Surgical pearl: surgical tape for dressing of epidermal grafts in lip vitiligo. J. Am. Acad. Dermatol. 53, 498 499.
132. Laxmisha, C. Thappa, D.M. (2006). Surgical pearl: use of hypodermic needle to transfer minigrafts. J. Am. Acad. Dermatol. 54, 707.
133. Lee, D.Y., Choi, Y.L., Kim, M.G., Kim, J.A., Lee, K.J. Lee, J.H. (2006). The effect of epidermal graft on a suction blistered donor wound. Dermatol. Surg. 32, 1305 1306.
134. Lee, K.J., Choi, Y.L., Kim, J.A., Kim, M.G., Lee, J.H., Yang, J.M. Lee, D.Y. (2007). Combination therapy of epidermal graft and systemic corticosteroid for vitiligo. Dermatol. Surg. 33, 1002 1003.
135. Lei, T.C., Vieira, W.D. Hearing, V.J. (2002). In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy. Pigment Cell Res. 15, 426 432.
136. Leone, G., Pacifico, A., Iacovelli, P., Paro Vidolin, A. Picardo, M. (2006). Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin. Exp. Dermatol. 31, 200 205.
137. Lepe, V., Moncada, B., Castanedo-Cazares, J.P., Torres-Alvarez, M.B., Ortiz, C.A. Torres-Rubalcava, A.B. (2003). A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch. Dermatol. 139, 581 585.
138. Levin, C. Maibach, H.I. (2002). Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am. J. Clin. Dermatol. 3, 141 147.
139. Lin, S.J., Jee, S.H., Hsaio, W.C., Lee, S.J. Young, T.H. (2005). Formation of melanocyte spheroids on the chitosan-coated surface. Biomaterials 26, 1413 1422.
140. Liu, J.Y., Hafner, J., Dragieva, G. Burg, G. (2004). Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant. 13, 809 816.
141. Lontz, W., Olsson, M.J., Moellmann, G. Lerner, A.B. (1994). Pigment cell transplantation for treatment of vitiligo: a progress report. J. Am. Acad. Dermatol. 30, 591 597.
142. Loomis, C.A., Koss, J. Chu, D. (2008). Embriology. In Dermatology, 2nd edn, J.L. Bolognia, J.L. Jorizzo R.P. Rapini, eds (Spain : Elsevier pp. 37 47.
143. Lotti, T., Buggiani, G., Troiano, M., Assad, G.B., Delescluse, J., De Giorgi, V. Hercogova, J. (2008). Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol. Ther. 21 Suppl 1, S20 S26.
144. Luger, T. Paul, C. (2007). Potential new indications of topical calcineurin inhibitors. Dermatology 215 Suppl 1, 45 54.
145. Mahmoud, B.H., Hexsel, C.L. Hamzavi, I.H. (2008). An update on new and emerging options for the treatment of vitiligo. Skin Therapy Lett. 13, 1 6.
146. Majumder, M.P. (2000). Genetics and prevalence of vitiligo vulgaris. In Vitiligo, S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science pp. 18 20.
147. Malakar, S. Dhar, S. (1998). Spontaneous repigmentation of vitiligo patches distant from the autologous skin graft sites: a remote reverse Koebner's phenomenon? Dermatology 197, 274.
148. Malakar, S. Dhar, S. (1999). Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients. Dermatology 198, 133 139.
149. Malakar, S. Lahiri, K. (2004). Punch grafting for lip leucoderma. Dermatology 208, 125 128.
150. Malakar, S., Lahiri, K. Malakar, R.S. (2000). How unstable is the concept of stability in surgical repigmentation of vitiligo? Dermatology 201, 182 183.
151. Mayoral, F.A., Vega, J.M., Stavisky, H., McCormick, C.L. Parneix-Spake, A. (2007). Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo. J. Drugs Dermatol. 6, 517 521.
152. McGovern, T.W., Bolognia, J. Leffell, D.J. (1999). Flip-top pigment transplantation: a novel transplantation procedure for the treatment of depigmentation. Arch. Dermatol. 135, 1305 1307.
153. Mehrabi, D. Pandya, A.G. (2006). A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol. 142, 927 929.
154. Menchini, G., Tsoureli-Nikita, E. Hercogova, J. (2003). Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J. Eur. Acad. Dermatol. Venereol. 17, 171 177.
155. Menchini, G., Lotti, T., Tsourelli-Nikita, E. Hercogová, J. (2004). Vitiligo: problems and non surgical solutions. In Vitiligo: Problems and Solutions, T. Lotti J. Hercogová, eds (New York, NY : Marcel Dekker Inc pp. 335 340.
156. Middelkamp-Hup, M.A., Bos, J.D., Rius-Diaz, F., Gonzalez, S. Westerhof, W. (2007). Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo controlled study. J. Eur. Acad. Dermatol. Venereol. 21, 942 950.
157. Morelli, J.G., Kincannon, J., Yohn, J.J., Zekman, T., Weston, W.L. Norris, D.A. (1992). Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J. Invest. Dermatol. 98, 290 295.
158. Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M. Fabbri, P. (2002). New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res. 15, 87 92.
159. Morison, W. (2000). PUVA therapy. In Vitiligo, S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science, Inc pp. 168 172.
160. Mou, K.H., Zhang, X.Q., Yu, B., Zhang, Z.L. Feng, J. (2004). Effects of endothelin-1 on melanocyte adhesion and migration. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29, 247 251.
161. Mulekar, S.V. (2003). Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int. J. Dermatol. 42, 132 136.
162. Mulekar, S.V. (2005). Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation. Int. J. Dermatol. 44, 841 845.
163. Mulekar, S.V. (2006). Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation. Dermatol. Surg. 32, 536 541.
164. Mulekar, S.V., Al Eissa, A. Asaad, M. (2005a). Koebnerization of donor site in unilateral vitiligo patients, treated successfully by autologous, noncultured melanocyte-keratinocyte (MK) cell transplantation. Clin. Exp. Dermatol. 30, 445 446.
165. Mulekar, S.V., Al Issa, A., Al Eisa, A. Asaad, M. (2005b). Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Dermatol. Surg. 31, 1737 1739 discussion 1740.
166. Mulekar, S.V., Asaad, M., Ghwish, B., Al Issa, A. Al Eisa, A. (2007). Koebner phenomenon in vitiligo: not always an indication of surgical failure. Arch. Dermatol. 143, 801 802.
167. Mulekar, S.V., Ghwish, B., Al Issa, A. Al Eisa, A. (2008). Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study. Br. J. Dermatol. 158, 45 49.
168. Nanda, S., Relhan, V., Grover, C. Reddy, B.S. (2006). Suction blister epidermal grafting for management of eyelid vitiligo: special considerations. Dermatol. Surg. 32, 387 391.
169. Navarro-Zorraquino, M., Garcia-Alvarez, F., Martinez-Fernandez, A.R., Pastor, C., Larrad, L., Salinas, J.C. Lozano, R. (2007). Pharmacological immunomodulation of surgical trauma. J. Invest. Surg. 20, 283 289.
170. Nicolaidou, E., Antoniou, C., Stratigos, A.J., Stefanaki, C. Katsambas, A.D. (2007). Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J. Am. Acad. Dermatol. 56, 274 278.
171. Njoo, M.D., Spuls, P.I., Bos, J.D., Westerhof, W. Bossuyt, P.M. (1998). Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch. Dermatol. 134, 1532 1540.
172. Njoo, M.D., Bos, J.D. Westerhof, W. (2000a). Treatment of generalized vitiligo in children with narrowband (TL-01) UVB radiation therapy. J. Am. Acad. Dermatol. 42, 245 253.
173. Njoo, M.D., Vodegel, R.M. Westerhof, W. (2000b). Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J. Am. Acad. Dermatol. 42, 760 769.
174. Nordlund, J.J. (2000). Depigmentation for the treatment of extensive vitiligo. In Vitiligo, S.K. Hann J.J. Nordlund, ed Luçon, France : Blackwell Science pp. 207 213.
175. Nordlund, J.J. Halder, R. (1990). Melagenina. An analysis of published and other available data. Dermatologica 181, 1 4.
176. 2 laser with a computerized pattern generator. Dermatol. Surg. 27, 565 568.
177. Olsson, M.J. Juhlin, L. (1995). Transplantation of melanocytes in vitiligo. Br. J. Dermatol. 132, 587 591.
178. Olsson, M.J. Juhlin, L. (1997). Epidermal sheet grafts for repigmentation of vitiligo and piebaldism, with a review of surgical techniques. Acta Derm. Venereol. 77, 463 466.
179. Olsson, M.J. Juhlin, L. (1998). Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br. J. Dermatol. 138, 644 648.
180. Olsson, M.J., Moellmann, G., Lerner, A.B. Juhlin, L. (1994). Vitiligo: repigmentation with cultured melanocytes after cryostorage. Acta Derm. Venereol. 74, 226 228.
181. Ongenae, K., Van Geel, N. Naeyaert, J.M. (2003). Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16, 90 100.
182. Ongenae, K., Van Geel, N., De Schepper, S. Naeyaert, J.M. (2005). Effect of vitiligo on self-reported health-related quality of life. Br. J. Dermatol. 152, 1165 1172.
183. Ongenae, K., Beelaert, L., van Geel, N. Naeyaert, J.M. (2006). Psychosocial effects of vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 1 8.
184. Orecchia, G.E. (2000). Neural pathogenesis. In Vitiligo, S.K. Hann J.J. Nordlund, eds (Luçon, France : Blackwell Science pp. 142 150.
185. Orecchia, G. Perfetti, L. (1992). Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 184, 120 123.
186. Ortel, B., Tanew, A. Honigsmann, H. (1988). Treatment of vitiligo with khellin and ultraviolet A. J. Am. Acad. Dermatol. 18, 693 701.
187. Ortonne, J.P., Pelletier, N., Chabanon, M. Thivolet, J. (1978). Vitiligo and cutaneous epitheliomas. Ann. Dermatol. Venereol. 105, 1063 1064.
188. Ortonne, J.P., MacDonald, D.M., Micoud, A. Thivolet, J. (1979). PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br. J. Dermatol. 101, 1 12.
189. Osawa, M., Egawa, G., Mak, S.S., Moriyama, M., Freter, R., Yonetani, S., Beermann, F. Nishikawa, S. (2005). Molecular characterization of melanocyte stem cells in their niche. Development 132, 5589 5599.
190. Ostovari, N., Passeron, T., Lacour, J.P. Ortonne, J.P. (2006). Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. Arch. Dermatol. 142, 252 253.
191. Pai, G.S., Vinod, V. Joshi, A. (2002). Efficacy of erbium YAG laser-assisted autologous epidermal grafting in vitiligo. J. Eur. Acad. Dermatol. Venereol. 16, 604 606.
192. Parsad, D., Pandhi, R., Dogra, S. Kumar, B. (2004). Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J. Am. Acad. Dermatol. 50, 63 67.
193. Parsad, D., Kanwar, A.J. Kumar, B. (2006). Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 175 177.
194. Pasricha, J.S. Khaitan, B.K. (1993). Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int. J. Dermatol. 32, 753 757.
195. Passeron, T. Ortonne, J.P. (2006). Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin. Dermatol. 24, 33 42.
196. Patel, D.C., Evans, A.V. Hawk, J.L. (2002). Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin. Exp. Dermatol. 27, 641 644.
197. Pathak, M.A. Fitzpatrick, T.B. (1992). The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J. Photochem. Photobiol. B 14, 3 22.
198. Peachey, R.D. (1971). Skin temperature and blood flow in relation to the speed of suction blister formation. Br. J. Dermatol. 84, 447 452.
199. Phillips, J., Gawkrodger, D.J., Caddy, C.M., Hedley, S., Dawson, R.A., Smith-Thomas, L., Freedlander, E. Mac Neil, S. (2001). Keratinocytes suppress TRP-1 expression and reduce cell number of co-cultured melanocytes - implications for grafting of patients with vitiligo. Pigment Cell Res. 14, 116 125.
200. Pianigiani, E., Risulo, M., Andreassi, A., Taddeucci, P., Ierardi, F. Andreassi, L. (2005). Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo. Dermatol. Surg. 31, 155 159.
201. Ponsonby, A.L., Lucas, R.M. van der Mei, I.A. (2005). UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 81, 1267 1275.
202. Porter, J.R. Beuf, A.H. (1991). Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J. Health Soc. Behav. 32, 192 204.
203. Radakovic-Fijan, S., Furnsinn-Friedl, A.M., Honigsmann, H. Tanew, A. (2001). Oral dexamethasone pulse treatment for vitiligo. J. Am. Acad. Dermatol. 44, 814 817.
204. Radmanesh, M. (2000). Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy. J. Eur. Acad. Dermatol. Venereol. 14, 149 152.
205. Radmanesh, M. Saedi, K. (2006). The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. J. Dermatolog. Treat. 17, 151 153.
206. Rao, J. Fitzpatrick, R.E. (2004). Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo. Dermatol. Surg. 30, 1043 1045.
207. Rayward, J., Villarrubia, V.G., Guillen, C., Prieto, A., Rodriguez-Zapata, M., Sada, G. Alvarez-Mon, M. (1997). An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitro. Int. J. Immunopharmacol. 19, 9 14.
208. Rezaei, N., Gavalas, N.G., Weetman, A.P. Kemp, E.H. (2007). Autoimmunity as an aetiological factor in vitiligo. J. Eur. Acad. Dermatol. Venereol. 21, 865 876.
209. Rivard, J., Hexsel, C., Owen, M., Strickland, F.M., Lim, H.W. Hamzavi, I. (2007). Photoadaptation of vitiliginous skin to targeted ultraviolet B phototherapy. Photodermatol. Photoimmunol. Photomed. 23, 258 260.
210. Roelandts, R. (1991). Which components in broad-spectrum sunscreens are most necessary for adequate UVA protection? J. Am. Acad. Dermatol. 25, 999 1004.
211. Sachdev, M. Shankar, D.S. (2000). Dermatologic surgery: pulsed erbium:YAG laser-assisted autologous epidermal punch grafting in vitiligo. Int. J. Dermatol. 39, 868 871.
212. Sanclemente, G., Garcia, J., Zuleta, J., Diehl, C., Correa, C. Falabella, R. (2008). A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo. J. Eur. Acad. Dermatol. Venereol. 22, 1359 1364.
213. Sardana, K., Bhushan, P. Kumar Garg, V. (2007). Effect of tacrolimus on vitiligo in absence of UV radiation exposure. Arch. Dermatol. 143, 119 author reply 120.
214. Schallreuter, K.U. Pittelkow, M.P. (1988). Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch. Dermatol. Res. 280, 137 139.
215. Schallreuter, K.U., Wood, J.M. Berger, J. (1991). Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97, 1081 1085.
216. Schallreuter, K.U., Wood, J.M., Pittelkow, M.R., Gutlich, M., Lemke, K.R., Rodl, W., Swanson, N.N., Hitzemann, K. Ziegler, I. (1994). Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263, 1444 1446.
217. Schallreuter, K.U., Moore, J., Wood, J.M., Beazley, W.D., Peters, E.M., Marles, L.K., Behrens-Williams, S.C., Dummer, R., Blau, N. Thony, B. (2001). Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J. Invest. Dermatol. 116, 167 174.
218. Schallreuter, K.U., Moore, J., Behrens-Williams, S., Panske, A. Harari, M. (2002). Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int. J. Dermatol. 41, 482 487.
219. Schallreuter, K.U., Kruger, C., Wurfel, B.A., Panske, A. Wood, J.M. (2008). From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int. J. Dermatol. 47, 743 753.
220. Sehgal, V.N., Srivastava, G. Dogra, S. (2008). Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I. Skinmed 7, 27 30.
221. Seirafi, H., Farnaghi, F., Firooz, A., Vasheghani-Farahani, A., Alirezaie, N.S. Dowlati, Y. (2007). Pimecrolimus cream in repigmentation of vitiligo. Dermatology 214, 253 259.
222. Sendur, N., Karaman, G., Sanic, N. Savk, E. (2006). Topical pimecrolimus: a new horizon for vitiligo treatment? J. Dermatolog. Treat. 17, 338 342.
223. Sethi, S., Mahajan, B.B., Gupta, R.R. Ohri, A. (2007). Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. Int. J. Dermatol. 46, 875 879.
224. Shen, Z., Gao, T.W., Chen, L., Yang, L., Wang, Y.C., Sun, L.C., Li, C.Y., Xiao, Y. Liu, Y.F. (2007). Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck. Photomed. Laser Surg. 25, 418 427.
225. Siddiqui, A.H., Stolk, L.M., Bhaggoe, R., Hu, R., Schutgens, R.B. Westerhof, W. (1994). L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 188, 215 218.
226. Silverberg, N.B., Lin, P., Travis, L., Farley-Li, J., Mancini, A.J., Wagner, A.M., Chamlin, S.L. Paller, A.S. (2004). Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J. Am. Acad. Dermatol. 51, 760 766.
227. Sitek, J.C., Loeb, M. Ronnevig, J.R. (2007). Narrowband UVB therapy for vitiligo: does the repigmentation last? J. Eur. Acad. Dermatol. Venereol. 21, 891 896.
228. Skouge, J. Morison, W.L. (1995). Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch. Dermatol. 131, 1257 1258.
229. Souza Leite, R.M. Craveiro Leite, A.A. (2007). Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream. Int. J. Dermatol. 46, 986 989.
230. Staricco, R.G. (1959). Amelanotic melanocytes in the outer sheath of the human hair follicle. J. Invest. Dermatol. 33, 295 297.
231. Suliman, M.T. Abdolmoneim, M. (2005). Severe burns following phototherapy with PUVA for vetiligo: a preventable complication that still happening. Burns 31, 1063.
232. Suvanprakorn, P., Dee-Ananlap, S., Pongsomboon, C. Klaus, S.N. (1985). Melanocyte autologous grafting for treatment of leukoderma. J. Am. Acad. Dermatol. 13, 968 974.
233. Taieb, A. (2007). NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders. Pigment Cell Res. 20, 260 262.
234. Tallab, T., Joharji, H., Bahamdan, K., Karkashan, E., Mourad, M. Ibrahim, K. (2005). Response of vitiligo to PUVA therapy in Saudi patients. Int. J. Dermatol. 44, 556 558.
235. Tegta, G.R., Parsad, D., Majumdar, S. Kumar, B. (2006). Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo. Int. J. Dermatol. 45, 106 110.
236. Thami, G.P. (2007). Micropigmentation. In Surgical Management of Vitiligo, S. Gupta, M.J. Olsson, A.J. Kanwar J.P. Ortonne, eds (Singapore : Blackwell Publishing pp. 249 254.
237. Theodoridis, A., Tsambaos, D., Sivenas, C. Capetanakis, J. (1976). Oral trimethylpsoralen in the treatment of vitiligo. Acta Derm. Venereol. 56, 253 256.
238. Tjioe, M., Gerritsen, M.J., Juhlin, L. van de Kerkhof, P.C. (2002). Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm. Venereol. 82, 369 372.
239. Tobin, D.J., Swanson, N.N., Pittelkow, M.R., Peters, E.M. Schallreuter, K.U. (2000). Melanocytes are not absent in lesional skin of long duration vitiligo. J. Pathol. 191, 407 416.
240. Tomita, Y., Iwamoto, M., Masuda, T. Tagami, H. (1987). Stimulatory effect of prostaglandin E2 on the configuration of normal human melanocytes in vitro. J. Invest. Dermatol. 89, 299 301.
241. Tomita, Y., Maeda, K. Tagami, H. (1992). Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 5, 357 361.
242. Tsuji, T. Hamada, T. (1983). Topically administered fluorouracil in vitiligo. Arch. Dermatol. 119, 722 727.
243. Tsukamoto, K., Osada, A., Kitamura, R., Ohkouchi, M., Shimada, S. Takayama, O. (2002). Approaches to repigmentation of vitiligo skin: new treatment with ultrasonic abrasion, seed-grafting and psoralen plus ultraviolet A therapy. Pigment Cell Res. 15, 331 334.
244. Valkova, S., Trashlieva, M. Christova, P. (2004). Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin. Exp. Dermatol. 29, 180 184.
245. Vussuki, E., Ziv, M., Rosenman, D. David, M. (2006). Long-term effects of PUVA therapy on Israeli patients with vitiligo. Harefuah, 145, 483 485, 551, 552.
246. Westerhof, W. d'Ischia, M. (2007). Vitiligo puzzle: the pieces fall in place. Pigment Cell Res. 20, 345 359.
247. Westerhof, W. Nieuweboer-Krobotova, L. (1997). Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch. Dermatol. 133, 1525 1528.
248. Wu, C.S., Lan, C.C., Wang, L.F., Chen, G.S., Wu, C.S. Yu, H.S. (2007). Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo. Br. J. Dermatol. 156, 122 129.
249. Yones, S.S., Palmer, R.A., Garibaldinos, T.M. Hawk, J.L. (2007). Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Arch. Dermatol. 143, 578 584.
250. Yu, H.S., Wu, C.S., Yu, C.L., Kao, Y.H. Chiou, M.H. (2003). Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J. Invest. Dermatol. 120, 56 64.